|Articles|March 1, 2001

Pharmaceutical Executive

  • Pharmaceutical Executive-03-01-2001
  • Volume 0
  • Issue 0

Surrounded

}Drug costs continue to rise at an alarming rate. Two major reasons for the increasing costs are introductions of new drugs and direct-to-consumer advertising campaigns that have been effective in marketing expensive name brand drugs.}

Articles in this issue

almost 25 years ago

Research: New Horizons

almost 25 years ago

Earnings: Tough Times Ahead

almost 25 years ago

Outbreak: Anthrax Alarm

almost 25 years ago

Patents: China on the Genome Map

almost 25 years ago

Privacy, Pediatrics, and Policy

almost 25 years ago

Lilly's International Family

almost 25 years ago

Update: Punishment and Reprieve

almost 25 years ago

Shortage: Vaccine Worries

almost 25 years ago

Gateway to Japan

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.